Tag Archive: Regulatory

2024-06-26

Redwood Pharma provides a new update regarding divestment of company assets

2024-05-23

Redwood Pharma provides an update on the company’s future

2023-11-30

Redwood Pharma AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ)

2023-05-31

Redwood Pharma presents positive results from a clinical study with RP501 against dry eye

2022-12-15

Redwood Pharma enters partnership with Nextec medical in preparation for European market clearance of RP501

2022-05-10

Redwood Pharma AB (publ) Quarterly report January–March 2022

2022-03-28

Redwood Pharma receives approval from the Austrian drug authority to start RP501 clinical trial

2022-02-16

Redwood Pharma AB (publ) Year-end report 2021

2021-10-25

Accelerating development of RP501 first-line therapy for dry eye disease

2021-08-27

Redwood Pharma AB (publ) Quarterly report January–June 2021